Benefits Handbook

MMC Benefits Handbook

All charges associated with a gestational carrier program for the person acting as the carrier, including but not limited to, fees for laboratory tests.
All costs associated with surrogate parenting including, but not limited to, donor oocytes (eggs), donor sperm and host uterus.
Assisted Reproductive Technology procedures done for non-genetic disorder sex selection or eugenic (selective breeding) purposes.
Cloning.
Cryopreservation and other forms of preservation of reproductive materials except as described under Fertility Treatment. This exclusion does not apply to short-term storage (less than one year) and retrieval of reproductive materials for which Benefits are provided as described under Fertility Preservation for Iatrogenic Infertility and Preimplantation Genetic Testing (PGT-M and PGT-SR) and Related Services.
Long-term storage (greater than one year) of reproductive materials such as sperm, eggs, embryos, ovarian tissue and testicular tissue.
Donor services and non-medical costs of oocyte or sperm donation (e.g., donor agency fees).
Embryo or oocyte accumulation, defined as a fresh oocyte (egg) retrieval prior to the depletion of previously banked frozen embryos or oocytes (eggs).
Natural cycle insemination in the absence of sexual dysfunction or documented congenital or acquired cervical disease or mild to moderate male factor.
Ovulation predictor kits.
Reversal of voluntary sterilization.
Infertility treatment with voluntary sterilization currently in place (vasectomy, bilateral tubal ligation).
Infertility treatment following unsuccessful reversal of voluntary sterilization.
Infertility Treatment following the reversal of voluntary sterilization (tubal reversal/reanastomosis; vasectomy reversal/vasovasostomy or vasoepididymostomy).
Pre-implantation Genetic Testing for Aneuploidy (PGT-A) used to select embryos for transfer in order to increase the chance for conception.
Services for partners, spouses, and the maternity expenses of gestational carriers not covered by the Surest Plan.
Treatments considered Experimental by the American Society of Reproductive Medicine.